Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-05-03

Clinical Trial Update: Fibrin Sealant in Eyelid Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a fibrin sealant in eyelid surgery, currently in phase 2 and phase 3 with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrin sealant (fibrin sealant)

Snippet

Sponsor: University of Calgary | Conditions: Blepharoptosis, Ecchymosis; Eyelid | Phase 2, Phase 3 | Status: UNKNOWN